Announcement on Obtaining the Drug Registration Certificate by a Subsidiary
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(600812)"North China Pharmaceutical Company. Ltd."Announcement on Obtaining the Drug Registration Certificate by a Subsidiary
Filed with SSE · Stock code 600812 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)North China Pharmaceutical Company Ltd. on 6ix
Story so far
- (600812)"North China Pharmaceutical Company Ltd."Announcement on Proposed Application for Unified Registration and Issuance of Debt Financing Instruments (PDFI)
- (600812)"North China Pharmaceutical Company Ltd."Announcement on Change in Accounting Policies
- (600812)"North China Pharmaceutical Company Ltd."Announcement on External Investment through Equity Participation and Related Party Transaction
Earlier from North China Pharmaceutical
- (600812)"North China Pharmaceutical Company Ltd."Report for Q3 2026
- (600812)"North China Pharmaceutical Company Ltd."Announcement on Resolutions of the 3rd Meeting of the 12th Board of Directors
- (600812)"North China Pharmaceutical Company Ltd."Announcement on Proposed Application for Unified Registration and Issuance of Debt Financing Instruments (PDFI)
- (600812)"North China Pharmaceutical Company Ltd."Announcement on External Investment through Equity Participation and Related Party Transaction
- (600812)"North China Pharmaceutical Company Ltd."Announcement on Change in Accounting Policies
Follow North China Pharmaceutical into a list and get an email when it puts out news.
Follow North China Pharmaceutical